319 0

Full metadata record

DC FieldValueLanguage
dc.contributor.author노영석-
dc.date.accessioned2018-04-03T07:38:03Z-
dc.date.available2018-04-03T07:38:03Z-
dc.date.issued2011-07-
dc.identifier.citation환경생물학회, 2011, 29(3), P.113-125en_US
dc.identifier.issn0494-4739-
dc.identifier.issn2287-7851-
dc.identifier.issn1226-9999-
dc.identifier.urihttp://kiss.kstudy.com/thesis/thesis-view.asp?key=2936331-
dc.identifier.urihttp://db.koreascholar.com/Article?code=5537-
dc.identifier.urihttp://hdl.handle.net/20.500.11754/57232-
dc.description.abstractAdalimumab is the first fully humanized monoclonal anti-tumor necrosis factor alpha (TNF-α) antibody. This drug has been shown to be of benefit in patients with inflammatory diseases in which TNF-α is involved, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn`s disease. As the use of adalimumab is becoming more widespread, cutaneous side effects are beingen_US
dc.language.isoko_KRen_US
dc.publisher한국환경생물학회 Korean Society Of Environmental Biologyen_US
dc.subjectAdalimumab,en_US
dc.subjectTNF-α inhibitoren_US
dc.subjectTNF-α inhibitoren_US
dc.titleAdalimumab에 의한 고리육아종-
dc.title.alternativeGranuloma Annulare Induced by Adalimumab-
dc.typeArticleen_US
dc.relation.no07-
dc.relation.volume49-
dc.relation.page656-659-
dc.relation.journal대한피부과학회지-
dc.contributor.googleauthor김미란-
dc.contributor.googleauthor이원철-
dc.contributor.googleauthorKim, Mi-Ran-
dc.contributor.googleauthorLee, Won-Choel-
dc.contributor.googleauthorZubrzycki Igor Z.-
dc.relation.code2012211861-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.pidromio-
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE